Europe Molecular Biosensors Market - Segmented by Application, Technology, Type, and Geography - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Europe Molecular Biosensors Market - Segmented by Application, Technology, Type, and Geography - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Europe Molecular Biosensors Market is expected to register a CAGR of 5.9% during the forecast period. A molecular biosensor is a device that uses specific biochemical reactions mediated by isolated enzymes, immunosystems, tissues, organelles, or whole cells to detect chemical compounds usually by electrical, thermal, or optical signals. Molecular biosensors are, thus, able to facilitate rapid detection and diagnosis at the POC, which make them particularly useful for an early and unequivocal diagnosis, and to prevent further disease spread.

In Europe, due to the increasing prevalence of chronic diseases, demand for point-of-care diagnostics has increased. This has led to an increase in demand for molecular biosensors. According to the International Diabetes Federation, in 2019, Germany had the highest prevalence of diabetes among the adult population in Europe with 15.3 percent of people with diabetes, followed by Portugal with 14.2 percent of people with diabetes. Thus, the above-mentioned factors have resulted in increased adoption of the molecular biosensor, which has helped the market growth.

Key Market TrendsElectrochemical Biosensors is Expected to Dominate the Market Over the Forecast Period

Electrochemical biosensors have emerged as reliable molecular sensing devices suitable for the detection of pathogens in liquid biopsies. Short assay time, simple handling, low cost, small sample requirement, and good performance in complex samples with minimal pre-treatments justify their increasing growth and suitability for point-of-care applications.

These biosensors are able to facilitate rapid detection and diagnosis at the point-of-care, which make them particularly useful for an early and unequivocal diagnosis, and to prevent further disease spread. In Europe, Methicillin-resistant Staphylococcus aureus (MRSA) infection remains an important pathogen in the European Union (EU) and European Economic Area (EEA) countries, as the levels of MRSA were high in several countries. In addition, in the EU/EEA population-weighted mean percentage for vancomycin-resistant Enterococcus faecium was increased from 10.5% in 2015 to 17.3% in 2018. Hence with an increase in infection from pathogens, the demand for fast point-of-care (POC) diagnostics like electrochemical biosensors is expected to increase in near future in Europe.

Competitive Landscape

The Europe Molecular Biosensors Market is consolidated competitive. The market players with more funds for research and better distribution system have established their position in the market. Some of the market players include Dynamic Biosensors GmbH, Abbott Laboratories Inc., Siemens Healthcare, Nova biomedical Corporation, Sysmex Corporation and Others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Companies Mentioned

Dynamic Biosensors GmbH
Abbott Laboratories Inc.
Siemens Healthcare
Nova biomedical Corporation
Sysmex Corporation
F. Hoffmann La Roche Ltd
Johnson and Johnson
Biacore (GE healthcare)
Medtronic Plc

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.